In Brief for May 24, 2023

ADAURA Demonstrates OS Benefit with Adjuvant Osimertinib in Resectable EGFRm NSCLC

Data Supporting IO Before Surgery in Resectable NSCLC Grows

From the Editors: Defining Resectability of Non-Small Cell Lung Cancer in 2023

Tumor Treating Fields May Provide Additional Treatment Option for mNSCLC Following Progression

In Brief for June 28, 2023

Adding Pembrolizumab to Platinum and Pemetrexed Improves OS in Treatment-Naive MPM

Exploratory IMpower010 Analysis Shows Surgery Type Associated with Favorable DFS, OS Results

In Brief for July 26, 2023

Program Covers Broad Spectrum of Topics in Thoracic Oncology

Make the Most of WCLC 2023: Mobile App Launches August 31

Know Before You Go: Getting To—And Around—Singapore